Cargando…
Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer
Colorectal cancer is one of the top causes of cancer and cancer-related deaths worldwide. The prognosis of metastatic colorectal cancer is poor and treatment options are limited. Many patients will run out of treatment options before they become medically unfit for therapy. As such, there is a need...
Autores principales: | Cimino, Sarah K, Eng, Cathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667584/ https://www.ncbi.nlm.nih.gov/pubmed/33204182 http://dx.doi.org/10.2147/JEP.S259287 |
Ejemplares similares
-
Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
por: Cann, Christopher G., et al.
Publicado: (2023) -
Targeting metastatic colorectal cancer – present and emerging treatment options
por: Ciombor, Kristen K, et al.
Publicado: (2014) -
Selecting treatment options in refractory metastatic colorectal cancer
por: Byrne, Margaret, et al.
Publicado: (2019) -
Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept
por: Dietvorst, Maria H. P., et al.
Publicado: (2013) -
Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019)